Adams and Victor's Principles of Neurology 11th Edition - 2019

Authors: Allan H. Ropper, Martin A. Samuels, Joshua Klein, Sashank Prasad

Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.

The definitive guide to understanding, diagnosing, and treating neurologic disease – more complete, timely, and essential than ever

A Doody’s Core Title for 2020! 

Adams and Victor’s Principles of Neurology is truly the classic text in its discipline --- a celebrated volume that guides clinicians to an in-depth understanding of the key aspects of neurologic disease, including both clinical and new scientific data. This meticulously revised and updated text remains the masterwork in its field, and the most readable reference available. Within its pages, you will find a disciplined presentation of clinical data and lucid descriptions of underlying disease processes.

Some of the features that have made this resource so renowned:

• The most cohesive and consistent approach to clinical management – acclaimed as the most readable book in the literature
• A scholarly approach that gives readers a comprehensive overview of every neurologic illness
• Unmatched coverage of signs and symptoms
• A focus on the full range of therapeutic options available to treat neurologic diseases, including drug therapy and rehabilitation methods
• Coverage of the most exciting discoveries and hypotheses of modern neuroscience that bear on and explain neurologic disease
• Puts the latest scientific discovery into a larger clinical context
• An evenness of style and a uniform approach to subject matter across disciplines that allows a quick and easy review of each topic and condition
• A rich, full-color presentation that includes many high-quality illustrations

The Eleventh Edition is enhanced by new coverage of :

• Interventional therapies for acute ischemic stroke
• Novel immunotherapies used to treat inflammatory and neoplastic conditions, and neurotoxicities associated with these drugs
• New drugs to treat epilepsy and multiple sclerosis
• Update of genetics of inherited metabolic disease
• Current understanding of the genetics of primary nervous system malignancies and their bearing on treatment